50 employees
Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for the COPD patients.
2007
$30M
from 2 investors over 2 rounds
Elevation Pharmaceuticals raised $17M on September 26, 2011
Investors: Canaan
Elevation Pharmaceuticals raised $30M on January 21, 2010